Similarly, COO subtypes and Ki-67 were not predictive factors for CD5+ DLBCL survival (Figure 2F, P = 0.064; data not shown for Ki-67, P = 0.118). The gene discussed is MKI67; the disease is diffuse large B-cell lymphoma.